Myc is a key regulator of cell growth, dierentiation and apoptosis, and aects cell fate decisions by activating as well as by inhibiting the expression of cellular genes. Myc is a member of the basic region ± helix ± loop ± helix ± leucine zipper (b-HLH-Zip) class of transcription factors, which heterodimerizes with the Max protein and recognizes a consensus Myc binding motif. 
Introduction
The c-myc gene is a key regulator of cell growth and plays a central role as a switch by which normal cells decide between alternative fates, such as proliferation, dierentiation and apoptosis (Amati and Land, 1994; Bouchard et al., 1998; Dang, 1999; Evan and Littlewood, 1993; Henriksson and LuÈ scher, 1996; Schmidt, 1999) . Numerous studies have shown that altered forms of the gene, such as retrovirally transduced (vmyc) or rearranged myc alleles, disturb the balance between these processes, resulting in tumorigenesis.
Myc proteins are nuclear phosphoproteins that display all the characteristics of transcription factors. The carboxyterminus of Myc functions as a basic region ± helix ± loop ± helix ± leucine zipper (b-HLH-Zip) DNAbinding domain, which heterodimerizes with the Max protein (Blackwood and Eisenman, 1991; LuÈ scher and Larsson, 1999; Prendergast and Zi, 1991) and recognizes a consensus Myc binding site. The aminoterminus of Myc contains a transcriptional activation domain (Kato et al., 1990) which is responsible for the activation of promoters containing Myc binding sites (Amati et al., 1992; Kretzner et al., 1992) . Besides Max a number of other cellular proteins have been shown to interact with dierent domains of Myc and to modulate its transcriptional properties (Sakamuro and Prendergast, 1999) .
It is widely believed that Myc exerts some of its functions by direct binding to and activation of cellular target genes (Cole and McMahon, 1999; Dang, 1999; Facchini and Penn, 1998; Grandori and Eisenman, 1997) . However, so far very few genes have unambiguously been shown to be direct Myc-regulated genes. Recent DNA microarray analyses suggest that Myc aects the expression of a large number of genes (Coller et al., 2000; Boon et al., 2001; Schuhmacher et al., 2001 ). The molecular mechanisms by which Myc regulates these genes have not been elucidated, however it is reasonable to suspect that Myc aects at least some of these genes by indirect mechanisms. Besides acting as a transcriptional activator Myc also downregulates the expression of certain genes (Claassen and Hann, 1999; Facchini and Penn, 1998) . Some of the genes repressed by Myc are themselves known to play critical roles during proliferation or dierentiation, suggesting that some of the biological functions of Myc are related to gene repression rather than activation. A recent example for the inhibitory role of Myc is the downregulation of the Cdk inhibitor p15
INK4b Staller et al., 2001) . We have been studying the mechanisms by which the v-Myc protein of the avian retrovirus MC29 regulates cellular gene expression. Recently, we have shown that Myc downregulates the expression of genes which are normally activated during myeloid dierentiation by interfering with the activity of several members of the CCAAT box/enhancer binding protein (C/EBP) family (Mink et al., 1996) . We show here that Myc can also stimulate the activity of other transcription factors. We present evidence that Myc increases the activity of the activating transcription factor 2 (ATF2). ATF2 is a member of the ATF/CREB protein family of basic region ± leucine zipper proteins (Hai et al., 1989; Maekawa et al., 1989) which play important roles in the cellular stress response (Gupta et al., 1995; Livingston et al., 1995; van Dam et al., 1993) . Several genes regulated by ATF2 have been identi®ed, including the c-jun, TNFa, TGFb, cyclin A, E-selectin and DNA polymerase b genes (Kim et al., 1992; Narayan et al., 1994; Read et al., 1997; Shimizu et al., 1998; Tsai et al., 1996; van Dam et al., 1993) . Although some of these ATF2 target genes have been implicated in the development of neoplasia, the possible contribution of ATF2 to this process so far is largely uncharacterized. We have begun to address the mechanism by which vMyc stimulates ATF2. Our results show that v-Myc prolongs the half-life of ATF2 and causes increased phosphorylation of ATF2 at sites that have been shown to be crucial for the regulation of ATF2 activity. Taken together, our results suggest a novel mechanism by which v-Myc might regulate the expression of cellular genes.
Results

Myc stimulates transactivation mediated by Gal4/ATF2
Previous work from our laboratory has shown that Myc inhibits the activity of C/EBPb and of other C/ EBP family members, leading to the downregulation of several C/EBP-dependent genes by Myc (Mink et al., 1996) . In the course of this work we have also studied the eects of Myc on several other transcription factors, including a Gal4/ATF2 fusion construct. Surprisingly, we found that Myc has a strong enhancing eect on the activity of Gal4/ATF2 ( Figure  1a ). The stimulatory eect of Myc was speci®c for the ATF2 part of the fusion protein, as other Gal4 fusion proteins, such as Gal4/VP16 (Figure 1b) or Gal4/cMyb ( Figure 1c) were not aected signi®cantly by Myc.
To explore the speci®city of the stimulatory eect of Myc on the activity of Gal4/ATF2 we analysed a series of Myc as well as Gal4/ATF2 deletion mutants. Figure  2a shows an analysis of a set of Myc mutants, which included several deletion mutants lacking amino-or carboxyterminal sequences (Myc-DN, Myc-DPA, Myc-D45 ± 83, Myc-D45 ± 97, Myc-DLZ), as well as point mutants of the HLH region (Myc-H1, Myc-H2). We found that none of the mutants had completely lost the ability to increase the activity of Gal4/ATF2, but that two of the mutants, the amino-terminal deletion mutant DPA and the carboxyterminal deletion mutant DLZ, had only approximately 20% of the stimulatory activity of wt Myc. As shown in Figure 2b all Myc mutants were expressed at similar levels, in particular those mutants which showed reduced activity were not expressed at lower levels. Thus, it appears that at least two regions of Myc, an N-terminal region as well as the leucine zipper domain contribute to the stimulatory eect.
Finally, we were interested to know whether the stimulatory eect on ATF2-dependent transcription was also observed for c-Myc. We therefore directly compared the eects elicited by v-Myc and chicken cMyc. As shown in Figure 2c ,d both proteins stimulated ATF2-dependent transcription to the same extent.
Myc increases the half-life of Gal4/ATF2
As a ®rst step to ®nding an explanation for the apparent increase of the activity of Gal4/ATF2, we determined the amounts of Gal4/ATF2 expressed in the absence or the presence of Myc. To our surprise we found that the amount of Gal4/ATF2 in the transfected cells was substantially increased in the presence of Myc (see left panel of Figure 3a ). Figure 3a also shows that the level of endogenous ATF2 in the transfected cells was not signi®cantly aected by Myc. Under the transfection conditions used only a small percentage of the cells (usually less than 5%) actually take-up the transfected DNA. The endogenous ATF2, visible in Figure 3a , is therefore predominantly (95%) derived from non-transfected cells, thus explaining the apparent dierence in the behavior of endogenous and exogenous ATF2.
To explain the increase of the amount of Gal4/ATF2 in the presence of Myc we ®rst considered the possibility that Myc might aect the CMV promoter which drives the expression of Gal4/ATF2. However, in a similar transfection experiment there was no obvious eect of Myc on the amount of C/EBPb expressed from a CMV promoter-containing expression vector (see right panel of Figure 3a ). Furthermore, we also did not observe any eect of Myc on the reporter plasmid CMVb, which contains the CMV promoter fused to the b-galactosidase gene and was used in all transfections to monitor the transfection eciency. Thus, we concluded that Myc does not increase the activity of the CMV promoter. To explain the elevated level of Gal4/ATF2 in the presence of Myc we therefore considered the alternative possibility that Myc might increase the half-life of Gal4/ATF2. To address this possibility we performed pulse ± chase experiments using cells transfected with the Gal4/ ATF2 expression vector alone or in combination with Myc. Transfected cells were labeled for 1 h with 35 Smethionine. Subsequently, they were transferred to a growth medium lacking radioactive methionine and supplemented with 1 mM of unlabeled methionine. The cells were then incubated in this medium for dierent periods of time, after which they were lysed and subjected to immunoprecipitation using Gal4-speci®c antibodies. Finally, the immunoprecipitated proteins were visualized by SDS ± PAGE and autoradiography. As shown in Figure 3b , the band corresponding to Gal4/ATF2 decreased much faster in the absence of Myc than in its presence (compare left and right panels at top of Figure 3b ). Quantitative analysis (bottom of Figure 3b ) also showed that the half-life of Gal4/ATF2 was less in the absence than in the presence of Myc.
Based on the initial decrease of the amounts of radiolabeled Gal4/ATF2, we estimate the half-life of the protein to be less than 1 h in the absence of Myc and approximately 3 h in its presence.
Since both ATF2 as well as Myc are degraded through the ubiquitin ± proteasome pathway (Ciechanover et al., 1991; Firestein and Feuerstein, 1998; Salghetti et al., 1999) we considered the possibility that Myc and ATF2 might compete with each other for a limiting component of the degradation machinery. If this was the case we would expect not only Myc to prolong the half-life of Gal4/ATF2 but also Gal4/ ATF2 to delay the degradation of Myc and, hence, to increase the amount of Myc. Figure 3c shows clearly that this was not the case. The amount of ATF2 was increased in the presence of Myc, however, at the same time the amount of Myc was not aected, arguing against competition of both proteins for the degradation machinery as an explanation for the stabilizing eect of Myc on ATF2.
Myc induces the phosphorylation of Gal4/ATF2
Recent work has linked the rate of degradation of ATF2 to N-terminal phosphorylation of ATF2 mediated by stress-activated protein kinases (Fuchs et al., 1997 (Fuchs et al., , 2000 Fuchs and Ronai, 1999) . In particular, it has been reported that phosphorylation of ATF2 at Thr-69 and Thr-71 by JNK/p38-dependent phosphorylation renders ATF2 resistant to ubiquitination and degradation. These observations suggested the possibility that Myc might increase the stability of ATF2 by inducing N-terminal phosphorylation of ATF2. To determine whether Myc aects the phosphorylation at Thr-69 and Thr-71 of Gal4/ ATF2 we used an antibody that speci®cally recognizes ATF2 phosphorylated at these aminoacid residues but does not react with unphosphorylated ATF2. Cells were transfected with expression vectors for Gal4/ ATF2 and Myc or for Gal4/ATF2 alone, followed by Western blot analysis of cell extracts using antibodies speci®c for ATF2 ( Figure 4 , left panel) or recognizing only phosphorylated ATF2 (Figure 4 , right panel). In this experiment we adjusted the amounts of cell extracts loaded onto the gel such that similar amounts of total Gal4/ATF2 were present in the two dierent lanes (left panel). As shown in the right panel of Figure 4 , the amount of Gal4/ATF2 phosphorylated at Thr-69 and Thr-71 was indeed increased in the presence of Myc. To further investigate the role of phosphorylation at Thr-69 and Thr-71 of ATF2 in mediating the Myc eect we used a mutant of Gal4/ATF2, in which the threonine residues at positions 69 and 71 of ATF2 have been mutated to alanine. Figure 5a shows that the overall transactivation activity of the mutant Gal4/ ATF2 was much lower than that of the unmutated protein, both in the absence or in the presence of Myc. This indicates that the transactivation domain of ATF2 is required for the Myc-dependent stimulation. Although Myc also aects the mutated protein the magnitude of stimulation was substantially less than observed in case of the unmutated protein (7.3-fold in case of Gal4/ATF2wt versus 3.3-fold in case of Gal4/ ATF2(Ala69,71). This demonstrates that the stimulatory eect of Myc depends, at least in part, on increased phosphorylation of Gal4/ATF2 at Thr-69 and Thr-71. However, phosphorylation at Thr-69 and Thr-71 does not account for all of the stimulatory eect of Myc, because transactivation mediated by the mutant Gal4/ATF2 is still stimulated by Myc, although less eciently.
Analysis of the amounts of the wild-type or mutant Gal4/ATF2 fusion proteins in the presence or absence of Myc showed that the mutant protein still accumulated in the presence of Myc, although the levels reached were somewhat lower than in case of the wildtype protein (Figure 5b ). Taken together these results suggest that Myc stimulates the transactivation potential of Gal4/ATF2 and causes accumulation of the protein, in part, by mechanisms which are dependent on phosphorylation at residues Thr-69 and Thr-71. However, it is also evident that the phosphorylation of these sites does not account for all of the eects induced by Myc.
Most of the experiments described above were performed by using arti®cial expression vectors transfected transiently into cells, a procedure which can give rise to artifacts due to the relatively high levels of expression of the proteins involved. We were therefore interested to see whether an eect of v-Myc on ATF2 could also be observed under more physiological conditions. To address this question we analysed the amount and phosphorylation state of (Symonds et al., 1986) and have been used before to demonstrate the inhibitory eect of Myc on the expression of C/EBP regulated genes (Mink et al., 1996) . As shown by Western blotting, both the amount of total ATF2 as well as of phosphorylated ATF2 was increased in the BM2(MC29)cl.4 cells compared to the original BM2 line. By contrast, an unrelated protein, v-Myb, was not aected (Figure 6a) .
In addition to these myeloid cells we analysed the levels of ATF2 and phosphorylated ATF2 in Myc knock-out ®broblasts and in the corresponding parental cell line (Mateyak et al., 1997) . As shown in Figure 3 v-Myc expression prolongs the half-life of Gal4/ATF2. (a) QT6 cells were transfected with 1 mg each of expression vectors for Gal4/ATF2 (pCDNA3 ± Gal4/ATF2) or C/EBPb (pCDNA3 ± CCR) and v-Myc (pCDNA3wtMyc), as indicated at the bottom. Transfection eciencies were normalized by co-transfecting 0.5 mg of the b-galactosidase reporter gene CMVb. Twentyfour hours after transfection total cell extracts were fractionated by SDS ± PAGE and analysed by Western blotting using ATF2-speci®c or C/EBPb-speci®c antibodies. Gal4/ATF2 and C/EBPb are marked by arrowheads. Endogenous ATF2 is seen as a minor band migrating slightly ahead of Gal4/ATF2. The band visible at the top of b is unspeci®c. Endogenous C/EBPb is not visible under these conditions. (b) QT6 cells were transfected as in a, except that 24 h after transfection cells were radiolabeled with 35 S-methionine for 1 h. Cells were then chased with an excess of unlabeled methionine for 0 h (lanes 1 and 5), 1 h (lanes 2 and 6), 2 h (lanes 3 and 7) and 4 h (lanes 4 and 8). Cell extracts were then immunoprecipitated with Gal4-speci®c antibodies and analysed by SDS ± PAGE and autoradiography (top). The radioactive bands corresponding to Gal4/ATF2 (arrow) were then quantitated by densitometry and the decrease of Gal4/ATF2 in the absence (crosses) or presence (circles) of Myc is shown against the time of chase (bottom). The band intensities at 0 h chase were designated as 100%. Lanes 1 ± 4: Gal4/ATF2 in the absence of Myc; Lanes 4 ± 8: Gal4/ATF2 in the presence of Myc. (c) QT6 cells were transfected with 1 mg each of expression vectors for full-length Gal4/ATF2 (pCDNA3-Gal4/ATF2) and v-Myc (pCDNA3wtMyc), as indicated at the bottom. Twentyfour hours after transfection total cell extracts were fractionated by SDS ± PAGE and analysed by Western blotting using Gal4-or Myc-speci®c antibodies. The bands corresponding to Gal4/ATF2 and Myc are marked by black and white arrows, respectively Figure 4 Myc causes increased phosphorylation of Gal4/ATF2 at Thr 69 and 71. QT6 cells were transfected with expression vectors for full-length Gal4/ATF2 (pCDNA3 ± Gal4/ATF2, 3 mg) and v-Myc (pCDNA3 ± wtMyc, 1 mg), as indicated at the bottom. Twenty-four hours after transfection total cell extracts were fractionated by SDS ± PAGE and analysed by Western blotting using ATF2-speci®c antibodies (left) or antibodies speci®c for ATF2 phosphorylated at Thr-69 and -71 (right). The amounts of cell extracts loaded on the gel were adjusted such that the same amount of total ATF2 was present in the dierent lanes. The bands corresponding to Gal4/ATF2 and to endogenous ATF2 are marked by black and white arrows, respectively Figure 6b , the levels of total ATF2, as well as of phosphorylated ATF2, were reduced in the cells lacking Myc protein. These results are consistent with our other observations and support the notion that Myc aects the amount and the phosphorylation status of ATF2.
Discussion
Myc is a key regulator of cell fate decisions which allow cells to switch between alternative fates such as proliferation, dierentiation or apoptosis. Myc is thought to act by activating the expression of certain cellular genes, as well as by downregulating the expression of others (Amati and Land, 1994; Bouchard et al., 1998; Dang, 1999; Evan and Littlewood, 1993; Henriksson and LuÈ scher, 1996; Schmidt, 1999 Schuhmacher et al., 2001) . According to the prevailing view gene activation by Myc is due to direct binding of Myc to its target genes, mediated by the DNA-binding domain located at the C-terminus of Myc (Cole and McMahon, 1999; Dang, 1999; Facchini and Penn, 1998; Grandori and Eisenman, 1997) . Although the expression of many genes is aected by Myc so far only few genes whose expression is activated by Myc as a result of direct Myc binding have been unambiguously identi®ed. It is, therefore, likely that Myc regulates the expression of at least some of its target genes indirectly.
In the work described here we have explored the possibility that Myc activates cellular gene expression by such indirect mechanisms. We have found that vMyc stimulates the activity of the transcription factor ATF2, suggesting a novel mechanism for gene activation by v-Myc. Together with our previous CMVb. Twenty-four hours after transfection total cell extracts were fractionated by SDS ± PAGE and analysed by Western blotting using ATF2-speci®c antibodies. The bands corresponding to Gal4/ATF2 and to endogenous ATF2 are marked by black and white arrows, respectively Figure 6 Analysis of endogenous ATF2 in the presence or absence of v-Myc. (a) Equivalent amounts of nuclear extracts from BM2 cells (B) or from BM2(MC29)cl.4 cells (M) were fractionated by SDS ± PAGE and analysed by Western blotting using antisera speci®c for ATF2 (left) or for ATF2 phosphorylated at Thr-69 and Thr-71 (middle) or for v-Myb (right). The black and white arrows mark endogenous ATF2 and v-Myb, respectively. (b) Equivalent amounts of extract from Myc+/+ (wt) or Myc 7/7 (ko) cells were analysed as in a using antisera speci®c for ATF2 (left) or for ATF2 phosphorylated at Thr-69 and Thr-71. The black arrow marks endogenous ATF2 work, which showed that v-Myc inhibits the activity of members of the C/EBP family (Mink et al., 1996) , our data suggest that v-Myc aects the expression of cellular genes by modulating the activity of other transcription factors, such as ATF2 or C/EBP. v-Myc has at least two eects on ATF2: Firstly, vMyc induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been shown to play key roles in the regulation of ATF2 activity. Phosphorylation at Thr-69 and Thr-71 by stress-activated kinases stimulates the transactivation potential of ATF2 and is crucial for the ability of ATF2 to mediate gene activation in response to stress (Gupta et al., 1995; Livingston et al., 1995; van Dam et al., 1995) . In addition, phosphorylation of ATF2 at Thr-69 and Thr-71 has been implicated in the regulation of the degradation of ATF2 by a ubiquitin ± proteasome dependent mechanism (Fuchs et al., 1997 (Fuchs et al., , 2000 Fuchs and Ronai, 1999) . Very recently, ATF2 has been shown to possess intrinsic histone acetyltransferase activity which is also in¯u-enced by phosphorylation of these N-terminal sites (Kawasaki et al., 2000) . Thus, phosphorylation at Thr-69 and Thr-71 of ATF-2 is a central event for the regulation of ATF2 activity. The relevance of these phosphorylation sites is further substantiated by our own data which implicate the phosphorylation of Thr-69 and Thr-71 in mediating the eects of v-Myc on ATF2. We can exclude the trivial possibility that the phosphorylation of Thr-69 and Thr-71 simply re¯ects a stress response, caused by the transfection procedure. In this case, we would expect control transfections (i.e. transfections lacking the v-Myc expression vector) to have the same eect on the phosphorylation status of ATF2.
Secondly, v-Myc increases the half-life of ATF2 and, thereby, causes an increase of the ATF2 protein levels. Our results show that the eect of v-Myc on the half-life of ATF2 is not simply due to overloading of the cellular protein degradation machinery caused by competition of ATF2 and v-Myc, which is itself a short-lived protein (Ciechanover et al., 1991; Firestein and Feuerstein, 1998; Salghetti et al., 1999) , for some limiting component of this machinery. If this was the case we would expect also to see an eect of ATF2 on the half-life of v-Myc, which was not observed. At present, we do not know whether or not the two eects of v-Myc which we have detected ± increase of half-life and induction of phosphorylation ± represent, in fact, the two sides of the same coin. As mentioned above, phosphorylation of ATF2 at Thr-69 and Thr-71 has been shown to extend the half-life of the protein (Ciechanover et al., 1991; Firestein and Feuerstein, 1998; Salghetti et al., 1999) ; thus the accumulation of ATF2 in the presence of Myc could simply be a consequence of the phosphorylation. Mutation of Thr-69 and Thr-71 to alanine residues has a signi®cant eect on the stimulation of the ATF2-dependent transactivation by Myc (which strongly suggests that phosphorylation of Thr-69 and Thr-71 is indeed involved in mediating the stimulatory eect of Myc) but, as shown in Figure 6 , has only a minor eect on the Myc-induced accumulation of ATF2. At ®rst glance, this suggests that the increase in the half-life and the stimulation of phosphorylation of ATF2 are independent events. However, it is possible that Myc induces phosphorylation of ATF2 at other as yet unknown sites and that phosphorylation of these sites also contributes to increased stability of the protein. In this case, stabilization of ATF2 would simply be a consequence of phosphorylation induced by Myc. However, it is also possible that induction of phosphorylation and stabilization of ATF2 are independent activities of Myc which both contribute to the increase in ATF2-mediated transactivation.
At present, we have not yet identi®ed the mechanisms by which Myc causes stabilization and phosphorylation of ATF2. As discussed above, stabilization could be simply a consequence of phosphorylation or could be induced independently. Since ATF2 is degraded by the ubiquitin-proteasome pathway, one possibility could be a modulation of the activity of some component(s) of this pathway. In this respect it would be very interesting to know if the stability of other proteins which are degraded by the same pathway are also aected by Myc. A possible scenario to explain the increase in phosphorylation of ATF2 by Myc envisions a stimulation of the activity of a member of the stress-activated protein kinase family by Myc, such as JNK or p38. To address this possibility it will be interesting to directly measure the activity of these kinases in the presence or absence of Myc.
Finally, it is worth considering potential target genes whose expression might be aected by v-Myc via ATF2. One interesting potential target in this respect is the cyclin A gene. Cyclin A expression is increased in a number of experimental cell systems overexpressing Myc (Daksis et al., 1994; Hoang et al., 1994; JansenDuÈ rr et al., 1993) . It has been suggested that the stimulation of the cyclin A promoter by Myc is mediated by the so-called CDE-and CHR-elements and involves a cyclin E-dependent kinase (Rudolph et al., 1996; Zwicker et al., 1995) . Interestingly, however, the cyclin A promoter also contains a conserved binding site for ATF2 in addition to these elements. Moreover, functional analyses have shown that the ATF2 binding site is essential for up-regulation of the cyclin A promoter in growth-stimulated human ®bro-blasts (Nakamura et al., 1995) and that ATF2 can stimulate the expression of the cyclin A gene (Shimizu et al., 1998) . Taken together, these observations raise the possibility that the stimulation of cyclin A expression by Myc is mediated, at least in part, by ATF2.
In conclusion, we have described a novel mechanism for gene activation by v-Myc. Our work suggests that Myc aects cellular gene expression not only by direct binding to speci®c target genes but also indirectly by modulating the activity of other transcription factors.
Materials and methods
Eukaryotic expression vectors
Expression vectors for the Gal4 DNA-binding domain (pSG424) and for full-length Gal4/ATF2 (pGal4/ATF2) have been described before (Li and Green, 1996; Green, 1990, 1994; Sadowski and Ptashne, 1989) and were kindly provided by M Green. pCDNA3 ± Gal4/ATF2 is a derivative of pSGATF-2, obtained by subcloning the Gal4/ATF2 coding region into expression vector pCDNA3 (Invitrogen). A Gal4/ATF expression vector carrying the T69A and T71A point mutations (Gupta et al., 1995) was kindly provided by R Davis. pGal4/VP16 encodes a Gal4/VP16 hybrid protein and was obtained from P Chambon. pGal4/c ± MybD3 encodes a Gal4/chicken c-Myb fusion protein lacking the C-terminus of c-Myb. pGal4/c-MybD3 was constructed by fusing the c-myb coding region of pCM107 (Burk et al., 1993) to the Gal4 DNA binding domain. Most of the expression vectors encoding wild-type or mutant v-Myc proteins have been described (Mink et al., 1996) . Myc ± DN encodes a Myc protein lacking aminoacids 1 ± 45. The full-length chicken cMyc expression vector SFCV ± c-Myc was obtained from D Crouch. To obtain comparable expression levels the chicken c-Myc coding region was excised from this vector and cloned into pCDNA3.
Cell lines
QT6 is a line of chemically transformed Japanese quail ®broblasts and was grown in Iscove's modi®ed DMEM supplemented with 8% (vol/vol) fetal calf serum and 2% (vol/vol) chicken serum (Moscovici et al., 1977) . BM2 is a line of avian myeloblastosis virus transformed chicken myeloblasts (Moscovici et al., 1982) . BM2(MC29)cl.4 is a derivative of the BM2 line obtained by infecting BM2 cells MC29 virus (Symonds et al., 1986) . BM2 and BM2(MC29) cells were grown in RPMI 1640 medium supplemented with 10% (vol/vol) tryptose phosphate broth, 5% (vol/vol) fetal calf serum and 5% (vol/vol) chicken serum. Wild-type and Myc-de®cient Rat1 ®broblasts (Mateyak et al., 1997) were obtained from J Sedivy and were grown in DMEM supplemented with 10% fetal calf serum.
Reporter genes, transfections, luciferase and b-galactosidase assays
The reporter plasmid pG5E4 ± 38Luc has been described (Kamano et al., 1995) . pCMVb was obtained from Clontech. Transfection of the quail ®broblast cell line QT6 was performed as described (Burk et al., 1993) . The amounts of DNA used for transfection of cells in a 10 cm tissue culture dish are indicated in the ®gure legends. Cells were harvested 24 h after transfection. Preparation of cell extracts, luciferase and b-galactosidase assays were performed as described (Burk et al., 1993) .
Antibodies and Western blotting
Monoclonal antibodies against the Gal4 DNA-binding domain (RK5C1) and polyclonal antisera against ATF2 (N-96) or phosphorylated ATF2 (F-1) were obtained from Santa Cruz Biotechnology. Polyclonal Myc-speci®c antiserum raised against the C-terminus of v-Myc was kindly provided by K Bister. Polyclonal Myb-speci®c antiserum has been described before (Klempnauer et al., 1983) . Total cell extract was prepared by lysing cells in SDS sample buer and boiling them for 5 min. Extracts were analysed by SDS ± PAGE and Western blotting as described (Mink et al., 1996) . Nuclei of BM2 and BM2(MC29)cl.4 cells were prepared by washing the cells twice in hypotonic buer (10 mM Tris-HCl, pH 7.8; 5 mM KCl; 2 mM MgCl 2 ) at 48C followed by incubation for 5 min in hypotonic buer supplemented with 0.2% NP-40. Nuclei were pelleted by centrifugation, washed twice with hypotonic buer and ®nally dissolved by boiling in SDSsample buer.
Radiolabeling of cells
Transfected cells were radiolabeled with 35 S-methionine (Amersham, 4800 Ci/mmol) in methionine-free medium at 100 mCi/ml for the indicated time period. Before labeling cells were pre-incubated in methionine-free medium for 30 min. Cells were then harvested immediately or were incubated further in a medium lacking radioactive methionine and supplemented with 1 mM of unlabeled methionine. For immunoprecipitation (all steps on ice) cells were lysed in lysis buer (10 mM Tris-HCl, pH 7.8; 50 mM NaCl; 0.5% sodium-deoxycholate; 0.5% NP-40; 0.1% SDS). The lysate was clari®ed by centrifugation and the appropriate antibodies were added, followed by incubation for 1 ± 2 h. Immunocomplexes were collected on staphylococcus aureus protein A conjugated sepharose beads, washed three times with lysis buer, once with PBS and bound radioactive proteins were visualized by SDS ± PAGE and autoradiography. Individual protein bands were quantitated using a phosphorimage analyzer.
